资讯
Doctors advise most patients on GLP-1 obesity drugs such as Wegovy and Zepbound to stay on them to keep the weight off, but ...
Eli Lilly (LLY) stock in focus as Texas sues the company for alleged bribery related to weight loss drugs like Zepbound and ...
Weight-loss patients voice concerns as CVS Caremark drops Zepbound coverage for Wegovy, though exceptions may exist for those ...
Danish drugmaker Novo Nordisk introduced its weight-loss drug Wegovy in South Africa on Thursday, marking its debut in Africa ...
Eli Lilly shares fell after the company’s oral drug showed less weight loss than hoped. It could still be huge.
Eli Lilly's new oral GLP-1 medication orforglipron produced an average weight loss of 12.4% (27.3 pounds) in clinical trials.
To make things a little less confusing, we’re here with all the info you need about popular weight loss med Mounjaro.
Texas Attorney General Ken Paxton on Tuesday sued U.S. drugmaker Eli Lilly for allegedly “bribing” providers to prescribe its ...
A former college athlete, 51-year-old Charles never thought he'd have to worry about his weight. But football injuries and a ...
1 天
Money Digest on MSNWeight Loss Drugs Medicare Covers For Seniors (If They Meet One Important Criteria)
Medicare covers weight loss drugs including Ozempic under specific conditions when the drug also has potential use cases beyond weight loss.
FOR years, Emma Morris hid from cameras, avoided mirrors and felt like a prisoner in her own body because of her weight. But ...
17 小时on MSN
Popular weight-loss drugs could increase risk of developing eye conditions, vision loss ...
One study found a modest risk of developing non-arteritic anterior ischaemic optic neuropathy (NAOIN), a rare eye condition ...
当前正在显示可能无法访问的结果。
隐藏无法访问的结果